Literature DB >> 18398784

Estrogen receptors in human pituitary tumors.

J A Burdman1, M Pauni, G M Heredia Sereno, A E Bordón.   

Abstract

The relationship between the presence of estrogen receptors in pituitary adenomas and the post surgical evolution of the patients in order to find another prognostic parameter for these tumors have been studied to improve the treatment selection. Estrogen receptors were studied by immunocytochemistry in histological sections of paraffin embedded 42 pituitary adenomas. Only 19% of these tumors were positive for estrogen receptors. As expected, the higher concentration (60%) was found in prolactin secreting adenomas, although we found estrogen receptors in one somatotroph and in one nonsecreting. The most aggressive tumors were those negative for estrogen receptors within the prolactinomas and the positive somatotrophinoma. The results of this work suggest that the determination of estrogen receptors in pituitary tumors might help as a prognostic factor in these adenomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398784     DOI: 10.1055/s-2008-1065338

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Authors:  T Chile; M L Corrêa-Giannella; M A H Z Fortes; M D Bronstein; M B Cunha-Neto; D Giannella-Neto; R R Giorgi
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior.

Authors:  Hakan Akinci; Aysegul Kapucu; Kadriye Akgun Dar; Ozlem Celik; Banu Tutunculer; Gozde Sirin; Buge Oz; Nurperi Gazioglu; Haluk Ince; Süheyla Aliustaoglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

3.  Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature.

Authors:  C Di Somma; E Scarano; G de Alteriis; L Barrea; E Riccio; R Arianna; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2020-09-07       Impact factor: 4.256

4.  Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients.

Authors:  Marta Araujo-Castro; Eider Pascual-Corrales; Alberto Acitores Cancela; Sara García Duque; Luis Ley Urzaiz; Víctor Rodríguez Berrocal
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633

5.  Increased expression of aromatase cytochrome P450 enzyme is associated with prolactinoma invasiveness in post-menopausal women.

Authors:  Yin-Xia Su; Guo-Li Du; Hong-Li Shen; Wen Wang; Jian-Ling Bao; Aizezijiang Aierken; Bo-Wei Wang; Sheng Jiang; Jun Zhu; Xiao-Ming Gao
Journal:  J Int Med Res       Date:  2019-06-10       Impact factor: 1.671

6.  Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas.

Authors:  Francesca Pecori Giraldi; Maria Francesca Cassarino; Antonella Sesta; Mariarosa Terreni; Giovanni Lasio; Marco Losa
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

7.  Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study.

Authors:  Chiara Bima; Sabrina Chiloiro; Antonella Giampietro; Marco Gessi; Pier Paolo Mattogno; Liverana Lauretti; Carmelo Anile; Guido Rindi; Alfredo Pontecorvi; Laura De Marinis; Antonio Bianchi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.